Published Date：Jan. 2021
Industry：Pharma & Healthcare
Pages：100 Table Number：123
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Axillary Hyperhidrosis Drug market in this environment. In terms of revenue, this research report indicated that the global Axillary Hyperhidrosis Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Axillary Hyperhidrosis Drug industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Allergan aims at producing XX Axillary Hyperhidrosis Drug in 2020, with XX % production to take place in global market, Brickell Biotech accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Axillary Hyperhidrosis Drug Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Axillary Hyperhidrosis Drug Market? Allergan Brickell Biotech Dermira Dr. August Wolff GmbH & Co KG Arzneimittle GlaxoSmithKline TheraVida ... Major Type of Axillary Hyperhidrosis Drug Covered in XYZResearch report: Botulinum ToxinA Glycopyrrolate Glycopyrronium Tosylate Others Application Segments Covered in XYZResearch Market Clinic Hospital Home Care For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Axillary Hyperhidrosis Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Botulinum ToxinA -Product Introduction and Major Manufacturers 1.1.2 Glycopyrrolate -Product Introduction and Major Manufacturers 1.1.3 Glycopyrronium Tosylate -Product Introduction and Major Manufacturers 1.1.4 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Axillary Hyperhidrosis Drug Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Axillary Hyperhidrosis Drug Market 3.1.1 Top Companies leading Axillary Hyperhidrosis Drug Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Axillary Hyperhidrosis Drug Market 3.2.1 Top Companies leading Axillary Hyperhidrosis Drug Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Axillary Hyperhidrosis Drug Market 3.3.1 Top Companies leading Axillary Hyperhidrosis Drug Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Axillary Hyperhidrosis Drug Market 3.4.1 Top Companies leading Axillary Hyperhidrosis Drug Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Axillary Hyperhidrosis Drug Market 3.5.1 Top Companies leading Axillary Hyperhidrosis Drug Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Axillary Hyperhidrosis Drug Market 3.6.1 Top Companies leading Axillary Hyperhidrosis Drug Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Axillary Hyperhidrosis Drug Market 3.7.1 Top Companies leading Axillary Hyperhidrosis Drug Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Axillary Hyperhidrosis Drug Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Axillary Hyperhidrosis Drug Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2026) 5.2 Global Axillary Hyperhidrosis Drug Sales Value and Growth Rate (2021-2026) 6 Axillary Hyperhidrosis Drug Competitive Analysis 6.1 Allergan 6.1.1 Allergan Company Profiles 6.1.2 Allergan Product Introduction 6.1.3 Allergan Axillary Hyperhidrosis Drug Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Brickell Biotech 6.2.1 Brickell Biotech Company Profiles 6.2.2 Brickell Biotech Product Introduction 6.2.3 Brickell Biotech Axillary Hyperhidrosis Drug Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Dermira 6.3.1 Dermira Company Profiles 6.3.2 Dermira Product Introduction 6.3.3 Dermira Axillary Hyperhidrosis Drug Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Dr. August Wolff GmbH & Co KG Arzneimittle 6.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Profiles 6.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Product Introduction 6.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 GlaxoSmithKline 6.5.1 GlaxoSmithKline Company Profiles 6.5.2 GlaxoSmithKline Product Introduction 6.5.3 GlaxoSmithKline Axillary Hyperhidrosis Drug Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 TheraVida 6.6.1 TheraVida Company Profiles 6.6.2 TheraVida Product Introduction 6.6.3 TheraVida Axillary Hyperhidrosis Drug Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Axillary Hyperhidrosis Drug Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Axillary Hyperhidrosis Drug Sales (K Unit) by Type (2015-2026) Figure Global Axillary Hyperhidrosis Drug Sales (K Unit) and Growth Rate (2015-2026) Figure Global Axillary Hyperhidrosis Drug Sales Market Share (%) by Type (2019 -2020) Table Global Axillary Hyperhidrosis Drug Sales Value (Million USD) by Type (2015-2026) Figure Global Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Axillary Hyperhidrosis Drug Sales Value Market Share (%) by Type (2019-2020) Table Global Axillary Hyperhidrosis Drug Sales (K Unit) by Application (2015-2026) Table China Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table China Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table China Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure China Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table China Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table China Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table China Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure China Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Table EU Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table EU Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table EU Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure EU Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table EU Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table EU Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure EU Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Table USA Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table USA Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table USA Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure USA Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table USA Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table USA Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure USA Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Table Japan Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table Japan Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table Japan Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table Japan Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table Japan Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure Japan Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Table India Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table India Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table India Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure India Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table India Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table India Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table India Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure India Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Table Southeast Asia Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table Southeast Asia Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table Southeast Asia Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure Southeast Asia Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Table South America Axillary Hyperhidrosis Drug Sales (K Unit) of Major Company (2015-2020) Table South America Axillary Hyperhidrosis Drug Sales Market Share of Major Company (2015-2020) Table South America Axillary Hyperhidrosis Drug Sales Value (Million USD) of Major Company (2015-2020) Figure South America Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Axillary Hyperhidrosis Drug Sales Value Share of Major Company (2015-2020) Table South America Axillary Hyperhidrosis Drug Price (USD/Unit), by Type (2019-2020) Table South America Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure South America Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Axillary Hyperhidrosis Drug Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Axillary Hyperhidrosis Drug Figure Cost Structure of Axillary Hyperhidrosis Drug in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Axillary Hyperhidrosis Drug Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Axillary Hyperhidrosis Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Allergan Profiles Table Allergan Axillary Hyperhidrosis Drug Product Introduction Table Allergan Axillary Hyperhidrosis Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Allergan SWOT Analysis Table Brickell Biotech Profiles Table Brickell Biotech Axillary Hyperhidrosis Drug Product Introduction Table Brickell Biotech Axillary Hyperhidrosis Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Brickell Biotech SWOT Analysis Table Dermira Profiles Table Dermira Axillary Hyperhidrosis Drug Product Introduction Table Dermira Axillary Hyperhidrosis Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Dermira SWOT Analysis Table Dr. August Wolff GmbH & Co KG Arzneimittle Profiles Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Introduction Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Dr. August Wolff GmbH & Co KG Arzneimittle SWOT Analysis Table GlaxoSmithKline Profiles Table GlaxoSmithKline Axillary Hyperhidrosis Drug Product Introduction Table GlaxoSmithKline Axillary Hyperhidrosis Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure GlaxoSmithKline SWOT Analysis Table TheraVida Profiles Table TheraVida Axillary Hyperhidrosis Drug Product Introduction Table TheraVida Axillary Hyperhidrosis Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
